Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Join the ASAP Webinar: Exploring Unusual Causes of Stroke — Supported by Moleac
World Stroke Day 2025 — Supporting Stroke Survivors to Reconnect with Life
Moleac at the Annual Neurosurgery Conference of Cambodia — Advancing Brain Injury Recovery with NeuroAiD
Moleac Walks for Stroke Awareness — Supporting SNSA’s Stepping Out for Stroke 2025
Moleac team was delighted to join the Stepping Out for Stroke 2025 walkathon, organized by the Singapore National Stroke Association (SNSA).
Moleac at CPHI Frankfurt 2025 — Expanding Global Partnerships in Innovative Medical Care
Moleac is excited to attend CPHI Frankfurt 2025!
Advancing Neurorecovery: Highlights from Moleac’s Dinner Symposium at the World Stroke Congress 2025
Thank you for joining us at our Dinner Symposium held alongside the World Stroke Congress 2025 in Barcelona!
Moleac Live at the World Stroke Congress 2025 — Discover Innovations in Neurovascular Repair and Stroke Recovery
We are live at the World Stroke Congress (WSC) in Barcelona!
MRI Markers Predict Stroke Recurrence and Mortality: Insights from a 2025 Meta-Analysis on Cerebral Small-Vessel Disease
Step Out with Moleac and SNSA for Stroke Awareness — Join the 2025 Walkathon in Singapore!
Join us in supporting the Singapore National Stroke Association (SNSA) at their annual walkathon, Stepping Out for Stroke 2025!
Meet Moleac at the World Stroke Congress 2025 in Barcelona — Advancing Stroke and Neurorehabilitation Care
Moleac will be attending the World Stroke Congress (WSC) from October 22–24, 2025, in Barcelona.
